Showing results (391-400 of 484) with videos related to

Sort By:
Pageof 49
The Oncologist|April 10, 2024
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master ProtocolJoel W Neal, Katherine Minichiello, Ryan Brennick, et al.
Nature Machine Intelligence|November 29, 2021
Radiological tumor classification across imaging modality and histologyJia Wu, Chao Li, Michael Gensheimer, et al.
JAMA Network Open|September 26, 2023
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung CancerChloe C Su, Julie T Wu, Eunji Choi, et al.
Annals of Neurology|December 7, 2023
Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple SclerosisSarah Knowles, Rod Middleton, Benjamin Cooze, et al.
Journal of Thoracic Imaging|December 9, 2017
Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial TumorsSukhmani K Padda, Donato Terrone, Lu Tian, et al.
Diabetes, Obesity & Metabolism|June 12, 2019
Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogsJustin M Gregory, Guillaume Kraft, Melanie F Scott, et al.
JCO Precision Oncology|June 21, 2021
Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III <i>EGFR</i>-Mutant Non-Small-Cell Lung CancerJoel W Neal, Daniel B Costa, Alona Muzikansky, et al.
Practical Radiation Oncology|July 20, 2022
Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung CancerMax Devine, David J Merriott, Hyunsoo J No, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2012
A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancerSarah B Goldberg, Jeffrey G Supko, Joel W Neal, et al.
British Journal of Cancer|December 3, 2013
A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancerH Chen, M R Modiano, J W Neal, et al.
Pageof 49